11/10
02:03 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "buy" rating.
Low
Report
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "buy" rating.
11/7
07:12 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
11/7
06:47 am
mgnx
MacroGenics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
MacroGenics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/6
04:30 pm
mgnx
MacroGenics to Participate in Upcoming Investor Conferences
Medium
Report
MacroGenics to Participate in Upcoming Investor Conferences
11/6
08:06 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Low
Report
MacroGenics, Inc. (NASDAQ: MGNX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
11/5
10:32 pm
mgnx
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/5
09:06 pm
mgnx
MacroGenics (MGNX) Beats Q3 Earnings and Revenue Estimates [Yahoo! Finance]
Low
Report
MacroGenics (MGNX) Beats Q3 Earnings and Revenue Estimates [Yahoo! Finance]
11/5
04:01 pm
mgnx
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
Medium
Report
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
11/4
07:20 am
mgnx
Earnings To Watch: Macrogenics Inc (MGNX) Reports Q3 2024 Result [Yahoo! Finance]
Medium
Report
Earnings To Watch: Macrogenics Inc (MGNX) Reports Q3 2024 Result [Yahoo! Finance]
11/2
02:10 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
10/30
07:30 am
mgnx
MacroGenics Announces Leadership Transition
Low
Report
MacroGenics Announces Leadership Transition
10/29
04:30 pm
mgnx
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
Low
Report
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
10/25
11:05 pm
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
10/25
05:15 pm
mgnx
Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders
Low
Report
Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders
10/23
05:39 pm
mgnx
Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and Maplebear - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
Medium
Report
Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and Maplebear - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
10/22
07:47 am
mgnx
TerSera Therapeutics to acquire global rights to MARGENZA [Seeking Alpha]
Low
Report
TerSera Therapeutics to acquire global rights to MARGENZA [Seeking Alpha]
10/22
07:30 am
mgnx
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
Low
Report
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
10/17
05:35 pm
mgnx
200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight [Yahoo! Finance]
Low
Report
200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight [Yahoo! Finance]
9/26
09:23 am
mgnx
Here's Why MacroGenics (NASDAQ:MGNX) Must Use Its Cash Wisely [Yahoo! Finance]
Low
Report
Here's Why MacroGenics (NASDAQ:MGNX) Must Use Its Cash Wisely [Yahoo! Finance]
9/25
10:00 am
mgnx
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX
9/24
07:00 pm
mgnx
Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MGNX
Low
Report
Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MGNX
9/24
02:15 pm
mgnx
Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNX
Low
Report
Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNX
9/24
12:57 pm
mgnx
Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX
Low
Report
Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX
9/24
11:25 am
mgnx
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX)
Low
Report
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX)
9/24
11:00 am
mgnx
The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against MacroGenics, Inc.
Low
Report
The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against MacroGenics, Inc.